These funds are proposed for the following activities: Scale up cotrimoxazole (CTX) prophylaxis for HIV-exposed and infected children; provide nutrition assessment, counseling and support; provide prevention, diagnosis and management of tuberculosis and other opportunistic infections (OI's); provide palliative care and psychosocial support. The funds will be used to improve linkages to Community Based Care including: under 5 child survival interventions and community HIV supported services. These activities will be achieved through training and on-site mentorship, establishment of coordinating committees with community-based organizations, advocacy and community mobilization. These activities will take place in Kilimanjaro, Tabora, Shinyanga, Lindi and Arusha.

These funds are proposed for the following activities: Implement updated WHO treatment guidelines to improve access to pediatric ART, including treatment of all HIV infected children <24 months;enhance the identification and diagnosis of HIV for infants and children through EID, PITC in in-patient and out-patient settings, immunization, OVC, and TB/HIV clinics; improve follow-up services for HIV-exposed infants and children and track and retain children in care and treatment; monitor response and adherence to treatment. These activities will be achieved through training, on-site mentorship, advocacy, community mobilization, and updating of tools for tracking and retention. These activities will take place in Kilimanjaro, Arusha, Shinyanga, Tabora and Lindi with the aim of enrolling 3109 new children on ART.

Mentorship towards accreditation of 4 district labs at $10,000 per lab and $200,000 for KCMC ISO accreditation

Maintain services related to implementation of the Three I's. It is estimated that around 20 % of new patients enrolling into ART would present with signs and symptoms of advanced HIV deasese and diagnosing TB among this group remains difficult as the routine diagnostic tests (AFB smear microscopy and/or chest X ray) are neither very sensitive nor very specific and un diagnosed TB remains a major cause of mortality in this group. To enhence TB diagnosis in this group, there is a high need of investing in sophisticated TB diagnostic tests e.g. Liquid culture and Line Probe Assays. To increase access to this service, EGPAF will coordinate transportation of sputum and/or blood samples to CTRL /MRH for Liquid culture and LPAs. SCMS will procure adequate MIGT and LPA reagents for CTRL and MRH. EGPAF should ensure TB screening and recording in the CTC2 is happening throughout the supported sites. Partcicipate in the pilot and subsequent scale up of Three I's. EGPAF will continue to provide services in 34 districts in 5 regions(Kilimanjaro, Arusha, Shinyanga, Tabora and Lindi)